OFFICIAL PUBLICATION OF

by its subsidiary APPco

Ozempic shortages to continue: Butler

Nicholas O’Donoghue 16/07/2024

Novo Nordisk “simply doesn’t have the factories” to meet growing demand for Ozempic, Health Minister says Shortages of Novo Nordisk’s diabetes medication, Ozempic (semaglutide) are likely to continue into 2025, while hormone replacement patches could be resolved by September, Mark Butler the Minister for Health and Aged Care warns. Speaking with Heidi Murphy on 3AW

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

Funding secured for non-8CPA programs

Medschecks and Diabetes MedsCheck are included and funded under the 8CPA. The programs under the 8CPA will be undergoing a…

Anthony Tassone

Eli Lilly clarifies Mounjaro availability

One would think they could have made a commercial decision eith a needle maker to supply requisite number of needles…

Erin Threlfall

Funding secured for non-8CPA programs

This is a big step forward in securing the sustainability and viability of HMRs and RMMRs. Remember there is an…

Debbie Rigby

Funding secured for non-8CPA programs

So well done to the PSA for securing this funding. So important that these very valuable program finally gets looked…

Bente Hart

Ozempic shortages to continue: Butler

Previous Research Roundup

Next NAPSA seeks new chairs

Shingles: managing a distressing skin condition

Impetigo: cause and treatment

Topical retinoids: versatile skin care ingredients

Ceramides: what are they and why are they important?

MENU

Previous Research Roundup

Next NAPSA seeks new chairs

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.